Literature DB >> 2848099

The active analog approach applied to the pharmacophore identification of benzodiazepine receptor ligands.

S Tebib1, J J Bourguignon, C G Wermuth.   

Abstract

Applied to seven potent benzodiazepine-receptor ligands belonging to chemically different classes, the active analog approach allowed the stepwise identification of the pharmacophoric pattern associated with the recognition by the benzodiazepine receptor. A unique pharmacophore model was derived which involves six critical zones: (a) a pi-electron rich aromatic (PAR) zone; (b) two electron-rich zones delta 1 and delta 2 placed at 5.0 and 4.5 A respectively from the reference centroid in the PAR zone; (c) a freely rotating aromatic ring (FRA) region; (d) an out-of-plane region (OPR), strongly associated with agonist properties; and (e) an additional hydrophobic region (AHR). The model accommodates all presently known ligands of the benzodiazepine receptor, identifies sensitivity to steric hindrance close to the delta 1 zone, accounts for R and S differential affinities and distinguishes requirements for agonist versus non-agonist activity profiles.

Mesh:

Substances:

Year:  1987        PMID: 2848099     DOI: 10.1007/bf01676959

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  26 in total

1.  Stereochemical features controlling binding and intrinsic activity properties of benzodiazepine-receptor ligands.

Authors:  P A Borea; G Gilli; V Bertolasi; V Ferretti
Journal:  Mol Pharmacol       Date:  1987-04       Impact factor: 4.436

2.  Theoretical structure-activity studies of benzodiazepine analogues. Requirements for receptor affinity and activity.

Authors:  G H Loew; J R Nienow; M Poulsen
Journal:  Mol Pharmacol       Date:  1984-07       Impact factor: 4.436

3.  2-Arylpyrazolo[4,3-c]quinolin-3-ones: novel agonist, partial agonist, and antagonist of benzodiazepines.

Authors:  N Yokoyama; B Ritter; A D Neubert
Journal:  J Med Chem       Date:  1982-04       Impact factor: 7.446

4.  Stereochemical basis of anticonvulsant drug action. II. Molecular structure of diazepam.

Authors:  A Camerman; N Camerman
Journal:  J Am Chem Soc       Date:  1972-01-12       Impact factor: 15.419

5.  Electronic factors in the structure-activity relationship of some 1,4-benzodiazepin-2-ones.

Authors:  T Blair; G A Webb
Journal:  J Med Chem       Date:  1977-09       Impact factor: 7.446

6.  Synthesis of 6-substituted beta-carbolines that behave as benzodiazepine receptor antagonists or inverse agonists.

Authors:  T J Hagen; P Skolnick; J M Cook
Journal:  J Med Chem       Date:  1987-04       Impact factor: 7.446

7.  Beta-carbolines: synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptors.

Authors:  M Cain; R W Weber; F Guzman; J M Cook; S A Barker; K C Rice; J N Crawley; S M Paul; P Skolnick
Journal:  J Med Chem       Date:  1982-09       Impact factor: 7.446

8.  Synthesis and anxiolytic activity of 6-(substituted-phenyl)-1,2,4-triazolo[4,3-b]pyridazines.

Authors:  J D Albright; D B Moran; W B Wright; J B Collins; B Beer; A S Lippa; E N Greenblatt
Journal:  J Med Chem       Date:  1981-05       Impact factor: 7.446

9.  Molecular heterogeneity of benzodiazepine receptors.

Authors:  W Sieghart; M Karobath
Journal:  Nature       Date:  1980-07-17       Impact factor: 49.962

10.  CGS 8216: receptor binding characteristics of a potent benzodiazepine antagonist.

Authors:  A J Czernik; B Petrack; H J Kalinsky; S Psychoyos; W D Cash; C Tsai; R K Rinehart; F R Granat; R A Lovell; D E Brundish; R Wade
Journal:  Life Sci       Date:  1982-01-25       Impact factor: 5.037

View more
  6 in total

1.  Evaluating molecular similarity using reduced representations of the electron density.

Authors:  Nathalie Meurice; Gerald M Maggiora; Daniel P Vercauteren
Journal:  J Mol Model       Date:  2005-05-12       Impact factor: 1.810

2.  Differential potentiation of GABAA receptor function by two stereoisomers of diimidazoquinazoline analogues.

Authors:  H K Im; W B Im; J F Pregenzer; J D Petke; B J Hamilton; D B Carter; P F Von Voigtlander; H C Hansen; M Kristiansen
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

3.  A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists.

Authors:  Y C Martin; M G Bures; E A Danaher; J DeLazzer; I Lico; P A Pavlik
Journal:  J Comput Aided Mol Des       Date:  1993-02       Impact factor: 3.686

4.  Differential affinity of dihydroimidazoquinoxalines and diimidazoquinazolines to the alpha 1 beta 2 gamma 2 and alpha 6 beta 2 gamma 2 subtypes of cloned GABAA receptors.

Authors:  W B Im; H K Im; J F Pregenzer; B J Hamilton; D B Carter; E J Jacobsen; R E TenBrink; P F VonVoigtlander
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

5.  The future of molecular dynamics simulations in drug discovery.

Authors:  David W Borhani; David E Shaw
Journal:  J Comput Aided Mol Des       Date:  2011-12-20       Impact factor: 3.686

Review 6.  A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor Model.

Authors:  Terry Clayton; Michael M Poe; Sundari Rallapalli; Poonam Biawat; Miroslav M Savić; James K Rowlett; George Gallos; Charles W Emala; Catherine C Kaczorowski; Douglas C Stafford; Leggy A Arnold; James M Cook
Journal:  Int J Med Chem       Date:  2015-11-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.